T-cell engagers, bispecifics and CAR-T are changing myeloma care fast. Two HSANZ events in Sydney and Adelaide will help you get up to speed, and the Adelaide seminar is free, with a virtual option.
Gain practical insights into understanding and responding to the evolving needs of people living with CML, from diagnosis through treatment and beyond.
As of 1 September 2026, nurse practitioners have been able to prescribe PBS-listed medicines for chronic myeloid leukaemia (CML) as a continuation of an existing therapy, where care is shared with a medical practitioner.
Living with inherited cancer risk can raise questions that extend far beyond clinical testing and treatment. A new suite of resources from Inherited Cancers Australia has been developed to help people and families navigate some of the practical, emotional and deeply personal issues that can accompany an inherited cancer risk.
Cancer nurses working across haematology and cancer care can bring an important perspective to improving awareness and understanding of Bone Marrow Failure Syndromes. Maddie Riewoldt’s Vision is inviting healthcare professionals to complete a short national needs assessment and help shape future education.
